Our Products | Home | About Us | Contact Us | Login
EPIFLO® Transdermal Continuous Oxygen Therapy [TCOT]
 
Clinical Information

EPIFLO®, a portable, 3 ounce device, is designed to heal chronic skin wounds – wounds that have failed to heal for 60 days or more-- by providing continuous oxygen flow to the wound site 24/7. The therapy boosts metabolism and re-establishes tissue function. The formation of new collagen, granulation, angiogenesis and epithelialization are all oxygen dependent and oxygen driven. Some clinicians suggest that EPIFLO® mimics the bloodstream in delivering oxygen to ischemic cells surrounding the chronic wound thus providing metabolic energy to allow normal wound healing to progress.

Case report studies are available on this web site and additional clinical data will be posted as available.

Clinical poster presentations

Publications

 
 
Copyrights © 2008-2010 All rights reserved by Ogenix®